Auf dieser Seite
01CVS Preis
02Momentaufnahme
03Chart
04Aktiensplits
05Über uns
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
25Handelssignale
26Meine Kennzahlen
CVS CVS Health Corporation Common Stock
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$86,46
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$69,5152-Wochen-Tief
$110,6852-Wochen-Hoch
Marktkapitalisierung (MRQ)
$110.50B
P/E (TTM)
22.8
EPS (TTM)
$3.79
Umsatz (TTM)
$415.09B
Ihre Abzeichen
52W-Spanne
$70–$111
Analystenbewertung
BUY
Kursziel
$116
P/E
22.8
ROE
6.2%
Nettogewinnmarge
1.2%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CVS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$86.46
Marktkapitalisierung (MRQ)
$110.50B
P/E (TTM)
22.8
EPS (TTM)
$3.79
Umsatz (TTM)
$415.09B
Dividendenrendite
3.1%
ROE (TTM)
6.2%
Verschuldungsgrad
0.0
52W-Spanne
$70–$111
CVS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 7. Juni 2005 | 2-for-1 | Vorwärts |
| 16. Juni 1998 | 2-for-1 | Vorwärts |
| 15. März 1989 | 2-for-1 | Vorwärts |
| 3. Mai 1983 | 2-for-1 | Vorwärts |
Über CVS Health Corporation Common Stock Unternehmensübersicht von Wikipedia
Die CVS Health Corporation (oft CVS genannt, vormals CVS Caremark Corporation, davor CVS Corporation) ist ein Einzelhandelsunternehmen der Pharmaziebranche in den Vereinigten Staaten. Der Unternehmenssitz befindet sich in Woonsocket, Rhode Island. Das Unternehmen ist im S&P 500 gelistet. CVS betreibt Geschäfte unter dem Namen CVS/pharmacy. CVS steht für Consumer Value Store.
Mit einem Umsatz von 322,5 Milliarden US-Dollar, bei einem Gewinn von 5,6 Mrd. USD, stand CVS Health im Jahr 2023 laut den Forbes Global 2000 auf Platz 65 der weltgrößten Unternehmen. Laut den Fortune 500 gehörte es 2016 zu den 20 umsatzstärksten Unternehmen weltweit und liegt hier auf Rang 6. Das Unternehmen kam im Juli 2023 auf eine Marktkapitalisierung von 88,92 Mrd. USD.
Im Juni 2023 gab es in den USA 9.572 CVS Pharmacy-Standorte. Der Bundesstaat mit den meisten CVS Pharmacy-Filialen war Kalifornien mit 1.133, also rund 12 % aller Filialen. Neben den Gesundheitsprodukten gibt es in den CVS Läden auch Lebensmittel für den täglichen Bedarf zu kaufen. Die Läden sind jedoch deutlich kleiner als die typischen amerikanischen Supermärkte (z. B. Walmart). Die CVS-Geschäfte ähneln sehr den Walgreens-Läden.
## Unternehmensgeschichte
Das Unternehmen wurde in Lowell, Massachusetts 1963 unter dem Namen Melville Corporation gegründet. 1990 erfolgte eine Fusion mit Peoples Drug aus Washington, D.C. Der Name wurde 1996 in CVS Corporation geändert. 1997 hatte CVS rund 1.400 Geschäfte und übernahm mit dem Konkurrenten Revco weitere 2500 Läden. Durch die Übernahme gelang die Ausweitung des Geschäfts von der Ostküste in den Raum des Südosten der Vereinigten Staaten und in das Gebiet von Ohio. Mit Arbor Drugs aus Michigan erfolgte eine weitere Übernahme und 2004 kaufte CVS 1.260 Filialen der Eckerd Corporation von JCPenney, wodurch eine Expansion in die Regionen Florida und Texas erfolgte. Anfang November 2006 gab CVS die Fusion mit dem Konkurrenten Caremark RX Inc. aus Nashville bekannt. Der Name des Konzerns lautete seitdem CVS Caremark Corporation und ist in allen US-Bundesstaaten vertreten.
Am 5. Februar 2014 kündigte das Unternehmen an, in allen 7600 Filialen bis Oktober 2014 den Verkauf von Zigaretten und anderen Tabakprodukten einzustellen. Das Unternehmen rechnet mit Umsatzeinbußen von rund zwei Milliarden US-Dollar. CEO Larry Merlo begründete diesen Schritt mit den Grundsätzen des Unternehmens. Die Firma wurde in CVS Health umbenannt. Im Dezember 2017 wurde die Übernahme des Versicherers Aetna durch CVS Health für 69 Milliarden US-Dollar bekanntgegeben.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealth Care
BrancheHealth Care
Mitarbeiter219.000
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$402.07B2017-12-31 → 2025-12-31
EPS$1.392017-12-31 → 2025-12-31
Freier Cashflow$7.81B2017-12-31 → 2025-12-31
Nettogewinnmarge1.2%2017-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CVS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 22.85-Jahres-Durchschnitt ≈25.5 | ≈25.5 | 23.3 | Überbewertet | |
| P/S (TTM) | 0.35-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 1.3 | Unterbewertet | |
| K/B (MRQ) | 1.45-Jahres-Durchschnitt ≈1.4 | ≈1.4 | 2.9 | Unterbewertet | |
| EV / EBITDA | 10.75-Jahres-Durchschnitt ≈6.1 | ≈6.1 | 11.4 | Unterbewertet | |
| Kurs / FCF (TTM) | 9.45-Jahres-Durchschnitt ≈9.9 | ≈9.9 | · | · | |
| Kurs / Cashflow (TTM) | 7.55-Jahres-Durchschnitt ≈7.6 | ≈7.6 | 9.8 | Fairer Wert | |
| EV / Revenue (EV / Umsatz) | 0.25-Jahres-Durchschnitt ≈0.2 | ≈0.2 | · | · | |
| EV / FCF | 12.75-Jahres-Durchschnitt ≈9.3 | ≈9.3 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 2.0 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CVS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 2.0%5-Jahres-Durchschnitt ≈2.8% | ≈2.8% | 8.3% | Unterdurchschnittlich | |
| EBITDA-Marge (TTM) | 3.1%5-Jahres-Durchschnitt ≈4.1% | ≈4.1% | 8.8% | Unterdurchschnittlich | |
| Vorgewinnmarge (TTM) | 1.4%5-Jahres-Durchschnitt ≈2.1% | ≈2.1% | 3.8% | Im Einklang | |
| Nettogewinnmarge (TTM) | 1.2%5-Jahres-Durchschnitt ≈1.6% | ≈1.6% | 5.1% | Unterdurchschnittlich | |
| ROA (TTM) | 1.9%5-Jahres-Durchschnitt ≈2.2% | ≈2.2% | 4.0% | Schwach | |
| ROE (TTM) | 6.2%5-Jahres-Durchschnitt ≈7.3% | ≈7.3% | 12.5% | Schwach | |
| ROIC | 5.0%5-Jahres-Durchschnitt ≈9.6% | ≈9.6% | 9.2% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CVS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Debt / Equity (Fremdkapital / Eigenkapital) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.4 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 0.95-Jahres-Durchschnitt ≈0.9 | ≈0.9 | 1.4 | Geringe Liquidität | |
| Quick Ratio (MRQ) | 0.65-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.8 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CVS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 7.8%5-Jahres-Durchschnitt ≈8.4% | ≈8.4% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 7.6%5-Jahres-Durchschnitt ≈8.7% | ≈8.7% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 8.4% | · | · | · | |
| EPS YoY (EPS VjV) | -62.0%5-Jahres-Durchschnitt ≈-8.5% | ≈-8.5% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -61.7%5-Jahres-Durchschnitt ≈-9.5% | ≈-9.5% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -24.7%5-Jahres-Durchschnitt ≈-11.4% | ≈-11.4% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -23.9% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -25.7%5-Jahres-Durchschnitt ≈-12.4% | ≈-12.4% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -24.4% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CVS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.65-Jahres-Durchschnitt ≈1.4 | ≈1.4 | 1.2 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 11.85-Jahres-Durchschnitt ≈11.1 | ≈11.1 | 15.6 | Unterdurchschnittlich | |
| Receivables Turnover (Forderungsumschlag) | 10.55-Jahres-Durchschnitt ≈11.5 | ≈11.5 | 10.5 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.8M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite3.1%
Ausschüttungsquote192.1%
Annualisierte Auszahlung≈$2.66
5J Div CAGR≈5.9%
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Jul 23, 2026 | $0,67 | USD | ≈2.5% |
| Apr 23, 2026 | $0,67 | USD | ≈3.4% |
| Jan 22, 2026 | $0,67 | USD | ≈3.2% |
| Okt 23, 2025 | $0,67 | USD | ≈3.3% |
| Jul 22, 2025 | $0,67 | USD | ≈4.4% |
| Apr 22, 2025 | $0,67 | USD | ≈4.1% |
| Jan 23, 2025 | $0,67 | USD | ≈4.9% |
| Okt 21, 2024 | $0,67 | USD | ≈4.6% |
| Jul 22, 2024 | $0,67 | USD | ≈4.5% |
| Apr 19, 2024 | $0,67 | USD | ≈3.6% |
| Jan 19, 2024 | $0,67 | USD | ≈3.4% |
| Okt 19, 2023 | $0,61 | USD | ≈3.4% |
| Jul 20, 2023 | $0,61 | USD | ≈3.2% |
| Apr 20, 2023 | $0,61 | USD | ≈3.2% |
| Jan 19, 2023 | $0,61 | USD | ≈2.6% |
| Okt 20, 2022 | $0,55 | USD | ≈2.4% |
| Jul 21, 2022 | $0,55 | USD | ≈2.3% |
| Apr 21, 2022 | $0,55 | USD | ≈2.0% |
| Jan 20, 2022 | $0,55 | USD | ≈2.0% |
| Okt 21, 2021 | $0,50 | USD | ≈2.3% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
22.0%
Nächster Bericht
Okt 27, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 29, 2026 | $2.58 | $1.87 | 38.0% |
| 31. März 2026 | $2.57 | $2.22 | 15.8% | |
| 31. Dezember 2025 | $1.09 | $1.00 | 8.8% | |
| 30. September 2025 | $1.60 | $1.38 | 15.7% | |
| 30. Juni 2025 | $1.81 | $1.47 | 23.0% | |
| 31. März 2025 | $2.25 | $1.72 | 30.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Cost of Revenue | $221.17B | $206.29B | $217.10B | $196.89B | $175.80B | $163.98B | $158.72B | · | $153.45B | $146.53B | $126.76B | |
| Gross Profit | · | · | · | · | · | · | · | · | $28.55B | $28.86B | $26.53B | |
| Operating Expenses | $397.41B | $364.29B | $344.03B | $314.51B | $278.80B | $254.79B | $244.79B | · | $18.81B | $18.45B | $17.05B | |
| Operating Income | $4.66B | $8.52B | $13.74B | $7.95B | $13.31B | $13.91B | $11.99B | · | $9.54B | $10.39B | $9.47B | |
| Interest Expense | · | · | $2.66B | $2.29B | $2.50B | $2.91B | $3.04B | · | $1.06B | $1.08B | $859M | |
| Interest Income | · | · | · | · | · | · | · | · | $21M | $20M | $21M | |
| Other Non-op | $112M | $99M | $88M | $169M | $182M | $206M | $124M | · | $-208M | $-28M | · | |
| Pretax Income | $2.14B | $6.15B | $11.17B | $5.84B | $10.54B | $9.77B | $9.00B | · | $8.27B | $8.64B | $8.62B | |
| Income Tax | $408M | $1.56B | $2.81B | $1.51B | $2.55B | $2.57B | $2.37B | · | $1.64B | $3.32B | $3.39B | |
| Net Income | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| EPS (Basic) | $1.40 | $3.67 | $6.49 | $3.29 | $6.07 | $5.48 | $5.10 | · | $6.47 | $4.93 | $4.66 | |
| EPS (Diluted) | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | · | $6.44 | $4.90 | $4.63 | |
| Shares (Basic) | 1,267,000,000 | 1,259,000,000 | 1,285,000,000 | 1,312,000,000 | 1,319,000,000 | 1,309,000,000 | 1,301,000,000 | · | 1,020,000,000 | 1,073,000,000 | 1,118,000,000 | |
| Shares (Diluted) | 1,271,000,000 | 1,262,000,000 | 1,290,000,000 | 1,323,000,000 | 1,329,000,000 | 1,314,000,000 | 1,305,000,000 | · | 1,024,000,000 | 1,079,000,000 | 1,126,000,000 | |
| EBITDA | $9.27B | $13.11B | $18.11B | $11.99B | $17.70B | $18.35B | $16.36B | · | $12.00B | $10.34B | $9.45B |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.45B | $8.59B | $8.20B | $12.95B | $9.41B | $7.85B | $5.68B | · | $1.70B | $3.37B | $2.46B | |
| Short-term Investments | $2.15B | $2.41B | $3.26B | $2.78B | $3.12B | $3.00B | $2.37B | · | $111M | $87M | $88M | |
| Receivables | $39.78B | $36.47B | $35.23B | $27.28B | $24.43B | $21.74B | $19.62B | · | $13.18B | $12.16B | $11.89B | |
| Inventory | $19.25B | $18.11B | $18.02B | $19.09B | $17.76B | $18.50B | $17.52B | · | $15.30B | $14.76B | $14.00B | |
| Other Current Assets | $5.09B | $3.08B | $3.15B | $2.64B | $5.29B | $5.28B | $5.11B | $4.53B | $945M | $660M | $722M | |
| Current Assets | $74.71B | $68.64B | $67.86B | $65.63B | $60.01B | $56.37B | $50.30B | $45.20B | $31.23B | $31.04B | $29.16B | |
| PP&E (Net) | · | · | · | $12.87B | $12.90B | $12.61B | $12.04B | $11.36B | $10.29B | $10.18B | $9.86B | |
| PP&E (Gross) | · | · | · | $34.60B | $33.55B | $31.31B | $28.93B | · | $24.29B | $22.80B | $21.04B | |
| Accum. Depreciation | · | · | · | $21.48B | $20.65B | $18.70B | $16.89B | · | $14.00B | $12.63B | $11.18B | |
| Goodwill | $85.48B | $91.27B | $91.27B | $78.15B | $79.12B | $79.55B | $79.75B | · | $38.45B | $38.25B | $38.11B | |
| Intangibles | $25.51B | $27.32B | $29.23B | $24.80B | $29.03B | $31.14B | $33.12B | $36.31B | $13.63B | $13.51B | $13.88B | |
| Other Non-current Assets | $7.11B | $4.79B | $4.66B | $4.62B | $4.71B | $4.62B | $4.60B | $4.53B | $1.42B | $1.49B | $1.44B | |
| Total Assets | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | $216.67B | $95.13B | $94.46B | $92.44B | |
| Accounts Payable | · | · | · | · | · | · | · | · | $8.86B | $7.95B | $7.49B | |
| Accrued Liabilities | $22.39B | $20.81B | $23.52B | $18.75B | $17.67B | $14.24B | $12.13B | $10.66B | $6.58B | $6.94B | $6.83B | |
| Short-term Debt | $0 | $2.12B | $200M | $0 | · | $0 | $0 | · | $1.28B | $1.87B | $0 | |
| Current Liabilities | $88.69B | $84.61B | $79.19B | $69.42B | $67.81B | $62.02B | $53.30B | $45.76B | $30.65B | $26.25B | $23.17B | |
| Capital Leases | $13.64B | $14.90B | $16.03B | $16.80B | $18.18B | $18.76B | $18.93B | $18.83B | $306M | · | · | |
| Deferred Tax | $3.83B | $3.81B | $4.31B | $4.02B | $6.27B | $6.79B | $7.29B | $7.74B | $3.00B | $4.21B | $4.22B | |
| Other Non-current Liabilities | $6.77B | $5.43B | $6.21B | $6.73B | $1.90B | $2.35B | $2.16B | $2.26B | $1.28B | $1.55B | $1.54B | |
| Total Liabilities | $178.16B | $177.49B | $173.09B | $156.51B | $157.62B | $161.01B | $158.28B | $157.95B | $57.44B | · | · | |
| Long-term Debt | · | · | · | · | · | · | $68.48B | $72.61B | $27.00B | $25.70B | $27.50B | |
| Total Debt | $0 | $2.12B | $200M | · | · | · | $3.78B | · | $27.00B | $27.53B | $27.46B | |
| Common Stock | · | $18M | $18M | $18M | $17M | $17M | $17M | · | $17M | $17M | $17M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $32.08B | $31.62B | $30.95B | |
| Retained Earnings | $61.20B | $62.84B | $61.60B | $56.40B | $54.91B | $49.64B | $45.11B | $41.09B | $43.56B | $38.98B | $35.51B | |
| Treasury Stock | $36.79B | $36.82B | $33.84B | $31.86B | $28.17B | $28.18B | $28.23B | · | $37.80B | $33.45B | $28.89B | |
| AOCI | $406M | $-120M | $-297M | $-1.26B | $965M | $1.41B | $1.02B | · | $-165M | $-305M | $-358M | |
| Stockholders' Equity | $75.21B | $75.56B | $76.46B | $71.47B | $75.08B | $69.39B | $63.86B | $58.40B | $37.69B | $36.83B | $37.20B | |
| Liabilities + Equity | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | · | $95.13B | $94.46B | $92.44B | |
| Shares Outstanding | 1,271,000,000 | 1,260,000,000 | 1,288,000,000 | 1,300,000,000 | 1,322,000,000 | 1,310,000,000 | 1,302,000,000 | · | 1,712,000,000 | 1,061,000,000 | 1,101,000,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.61B | $4.60B | $4.37B | $4.22B | $4.49B | $4.44B | $4.37B | · | $2.48B | $2.48B | $2.09B | |
| Stock-based Comp | $535M | $540M | $588M | $447M | $484M | $400M | $453M | · | $234M | $222M | $230M | |
| Deferred Tax | $102M | $-572M | $-676M | $-2.03B | $-402M | $-564M | $-649M | · | $-1.42B | $3M | $-234M | |
| Amort. of Intangibles | $2.00B | $2.00B | $1.90B | $1.80B | $2.20B | $2.30B | $2.40B | · | $817M | $795M | $611M | |
| Restructuring | · | · | · | · | · | · | · | · | $215M | · | · | |
| Other Non-cash | $3.63B | $-72M | $804M | $9.41B | $5.79B | $4.41B | $2.04B | · | $93M | · | · | |
| Operating Cash Flow | $10.64B | $9.11B | $13.43B | $16.18B | $18.27B | $15.87B | $12.85B | · | $8.01B | $10.14B | $8.54B | |
| CapEx | $2.83B | $2.78B | $3.03B | $2.73B | $2.52B | $2.44B | $2.46B | · | $1.92B | $2.22B | $2.37B | |
| Investing Cash Flow | $-5.87B | $-7.61B | $-20.89B | $-5.05B | $-5.26B | $-5.53B | $-3.34B | · | $-2.88B | $-2.47B | $-13.42B | |
| Debt Issued | $3.97B | $7.91B | $10.90B | $0 | $987M | $9.96B | $3.74B | · | $0 | $3.46B | $14.80B | |
| Net Debt Issued | $340M | $3.14B | $7.73B | $-4.21B | $-9.27B | $-5.67B | $-4.60B | · | · | $-2.49B | $11.90B | |
| Stock Repurchased | $0 | $3.02B | $2.01B | $3.50B | $0 | $0 | $0 | · | $4.36B | $4.46B | $5.00B | |
| Net Stock Activity | $0 | $-3.02B | $-2.01B | $-3.50B | · | · | $0 | · | $-4.36B | $-4.46B | $-5.00B | |
| Dividends Paid | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B | |
| Financing Cash Flow | $-4.94B | $-1.14B | $2.68B | $-10.52B | $-11.36B | $-7.70B | $-7.65B | · | $-6.75B | $-6.76B | $4.88B | |
| Net Change in Cash | $-172M | $359M | $-4.78B | $614M | $1.65B | $2.63B | $1.85B | · | $-1.62B | $912M | $-22M | |
| Taxes Paid | $2.17B | $1.70B | $3.52B | $4.12B | $3.19B | $2.93B | $2.72B | · | $2.91B | $3.06B | $3.27B | |
| Free Cash Flow | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B | $13.43B | $10.39B | · | $6.09B | $7.84B | $6.04B | |
| Levered FCF | · | · | $8.40B | $11.76B | $13.85B | $11.29B | $8.15B | · | $5.24B | $7.18B | $5.52B |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 15.4% | 16.3% | 17.3% | |
| Operating Margin | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% | 5.2% | 4.7% | · | 5.1% | 5.8% | 6.2% | |
| Net Margin | 0.44% | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% | 2.6% | · | 3.6% | 3.0% | 3.4% | |
| Pretax Margin | 0.53% | 1.7% | 3.1% | 1.8% | 3.6% | 3.6% | 3.5% | · | 4.5% | 4.9% | 5.6% | |
| EBITDA Margin | 2.3% | 3.5% | 5.1% | 3.7% | 6.1% | 6.8% | 6.4% | · | 6.5% | 5.8% | 6.2% | |
| ROA | 0.70% | 1.8% | 3.5% | 1.8% | 3.4% | 3.2% | 3.0% | · | 7.0% | 5.7% | 6.2% | |
| ROE | 2.4% | 6.1% | 11.3% | 5.7% | 10.9% | 10.8% | 10.8% | · | 17.8% | 14.4% | 13.9% | |
| ROIC | 5.0% | 8.2% | 13.4% | 8.1% | 13.3% | 14.8% | 13.1% | · | 11.8% | 9.9% | 8.9% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.2 | 1.3 | |
| Quick Ratio | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | · | · | · | 0.1 | · | 0.7 | 0.7 | 0.7 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | 0.6 | 0.7 | 0.7 | |
| Interest Coverage | · | · | 5.2 | 3.4 | 5.3 | 4.8 | 3.9 | · | 9.0 | 9.6 | 11.0 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.5 | 1.5 | 1.4 | 1.3 | 1.2 | 1.2 | · | 1.9 | 1.9 | 1.8 | |
| Inventory Turnover | 11.8 | 11.4 | 11.7 | 10.7 | 9.7 | 9.1 | 9.3 | · | 10.4 | 10.3 | 9.8 | |
| Receivables Turnover | 10.5 | 10.4 | 11.4 | 12.5 | 12.7 | 13.0 | 13.8 | · | 14.6 | 14.8 | 14.2 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $59.18 | $59.97 | $59.36 | $54.63 | $56.79 | $52.97 | $49.05 | · | $37.17 | $34.71 | $33.78 | |
| Revenue / Share | $316.34 | $295.41 | $277.35 | $243.74 | $219.80 | $204.49 | $196.76 | · | $180.43 | $164.53 | $136.14 | |
| Cash Flow / Share | $8.37 | $7.22 | $10.41 | $12.23 | $13.74 | $12.07 | $9.85 | · | $7.82 | $9.33 | $7.47 | |
| Cash / Share | $6.65 | $6.81 | $6.36 | $9.96 | $7.12 | $6.00 | $4.36 | · | $1.67 | $3.18 | $2.23 | |
| Dividend / Share | $2.66 | $2.66 | $2.42 | $2.20 | $2.00 | $2.00 | $2.00 | · | $2.00 | $1.70 | $1.40 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | $2.00 | · | · | |
| EPS (TTM) | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | · | $6.44 | $4.90 | $4.63 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.8% | 4.2% | 10.9% | 10.4% | 8.7% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.6% | 8.5% | 10.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -62.0% | -43.4% | 98.5% | -45.9% | 10.3% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -24.7% | -15.3% | 5.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -23.9% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -61.7% | -44.7% | 93.5% | -46.1% | 11.5% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -25.7% | -16.8% | 5.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -24.4% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 5.3% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Net Income TTM | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| Market Cap | $100.87B | $56.56B | $101.70B | $121.15B | $136.38B | $89.47B | $96.73B | · | $73.52B | $83.72B | $107.64B | |
| Enterprise Value | $90.27B | $47.69B | $90.45B | · | · | · | $92.45B | · | $98.71B | $107.80B | $132.56B | |
| P/E | 57.1 | 12.3 | 12.2 | 28.6 | 17.1 | 12.5 | 14.6 | · | 11.3 | 16.1 | 21.1 | |
| P/S | 0.3 | 0.2 | 0.3 | 0.4 | 0.5 | 0.3 | 0.4 | · | 0.4 | 0.5 | 0.7 | |
| P/B | 1.3 | 0.7 | 1.3 | 1.7 | 1.8 | 1.3 | 1.5 | · | 2.0 | 2.3 | 2.9 | |
| P / Cash Flow | 9.5 | 6.2 | 7.6 | 7.5 | 7.5 | 5.6 | 7.5 | · | 9.2 | 8.3 | 12.8 | |
| P / FCF | 12.9 | 8.9 | 9.8 | 9.0 | 8.7 | 6.7 | 9.3 | · | 12.1 | 10.7 | 17.8 | |
| EV / EBITDA | 9.7 | 3.6 | 5.0 | · | · | · | 5.7 | · | 8.2 | 10.4 | 14.0 | |
| EV / FCF | 11.6 | 7.5 | 8.7 | · | · | · | 8.9 | · | 16.2 | 13.7 | 21.9 | |
| EV / Revenue | 0.2 | 0.1 | 0.3 | · | · | · | 0.4 | · | 0.5 | 0.6 | 0.9 | |
| Dividend Yield | 3.4% | 6.0% | 3.1% | 2.4% | 1.9% | 2.9% | 2.7% | · | 2.8% | 2.2% | 1.5% | |
| Earnings Yield | 1.8% | 8.2% | 8.2% | 3.5% | 5.8% | 8.0% | 6.8% | · | 8.9% | 6.2% | 4.7% | |
| Payout Ratio | 192.1% | 73.1% | 37.5% | 70.1% | 33.2% | 36.5% | 39.2% | · | 30.9% | 34.6% | 30.1% | |
| Annual Payout | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $106.10B | $100.43B | $105.69B | $102.87B | $98.92B | $94.59B | $97.71B | $95.43B | $91.23B | $88.44B | $93.81B | $89.76B | $88.92B | $85.28B | $83.85B | $81.16B | |
| Cost of Revenue | $58.86B | $55.44B | $59.06B | $57.05B | $54.01B | $51.06B | $55.27B | $52.95B | $50.00B | $48.07B | $57.42B | $54.69B | $53.54B | $51.45B | $51.73B | $50.37B | |
| Operating Expenses | $101.39B | $95.75B | $103.58B | $106.08B | $96.53B | $91.21B | $95.34B | $94.60B | $88.19B | $86.17B | $90.44B | $86.07B | $85.69B | $81.83B | $80.19B | $85.08B | |
| Operating Income | $4.70B | $4.68B | $2.11B | $-3.21B | $2.38B | $3.37B | $2.37B | $832M | $3.04B | $2.27B | $3.37B | $3.69B | $3.23B | $3.45B | $3.66B | $-3.92B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $716M | · | $693M | $686M | $589M | · | $566M | |
| Other Non-op | $31M | $32M | $29M | $26M | $29M | $28M | $25M | $25M | $24M | $25M | $22M | $22M | $22M | $22M | $43M | $41M | |
| Pretax Income | $3.98B | $3.94B | $1.35B | $-3.48B | $1.65B | $2.62B | $2.13B | $105M | $2.34B | $1.58B | $2.71B | $3.02B | $2.57B | $2.88B | $3.15B | $-4.44B | |
| Income Tax | $982M | $981M | $-1.57B | $508M | $634M | $835M | $503M | $34M | $569M | $456M | $658M | $754M | $656M | $737M | $818M | $-1.04B | |
| Net Income | $2.98B | $2.94B | $2.94B | $-3.98B | $1.02B | $1.78B | $1.64B | $87M | $1.77B | $1.11B | $2.05B | $2.26B | $1.90B | $2.14B | $2.33B | $-3.41B | |
| EPS (Basic) | $2.33 | $2.31 | $2.31 | $-3.13 | $0.81 | $1.41 | $1.31 | $0.07 | $1.41 | $0.88 | $1.59 | $1.76 | $1.48 | $1.66 | $1.78 | $-2.59 | |
| EPS (Diluted) | $2.31 | $2.30 | $2.31 | $-3.13 | $0.80 | $1.41 | $1.30 | $0.07 | $1.41 | $0.88 | $1.59 | $1.75 | $1.48 | $1.65 | $1.79 | $-2.59 | |
| Shares (Basic) | 1,279,000,000 | 1,273,000,000 | · | 1,269,000,000 | 1,266,000,000 | 1,261,000,000 | · | 1,259,000,000 | 1,256,000,000 | 1,260,000,000 | · | 1,287,000,000 | 1,283,000,000 | 1,283,000,000 | · | 1,315,000,000 | |
| Shares (Diluted) | 1,287,000,000 | 1,279,000,000 | · | 1,269,000,000 | 1,270,000,000 | 1,264,000,000 | · | 1,259,000,000 | 1,259,000,000 | 1,267,000,000 | · | 1,290,000,000 | 1,287,000,000 | 1,291,000,000 | · | 1,315,000,000 | |
| EBITDA | $5.83B | $5.79B | · | $-2.07B | $3.55B | $4.53B | · | $832M | $3.04B | $3.41B | · | $3.69B | $3.23B | $4.45B | · | $-3.93B |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11.33B | $9.54B | $8.45B | $9.10B | $11.79B | $10.08B | $8.59B | $6.88B | $12.51B | $9.80B | $8.20B | $13.04B | $13.81B | $14.62B | $12.95B | $17.20B | |
| Short-term Investments | $2.63B | $2.26B | $2.15B | $2.13B | $2.39B | $2.58B | $2.41B | $2.81B | $3.75B | $3.29B | · | $3.15B | $3.08B | $3.10B | · | $2.79B | |
| Receivables | $40.31B | $40.99B | $39.78B | $43.86B | $40.65B | $39.62B | $36.47B | $36.18B | $32.38B | $32.22B | · | $32.93B | $29.55B | $28.33B | · | $26.32B | |
| Inventory | $17.62B | $17.77B | $19.25B | $18.96B | $17.45B | $17.39B | $18.11B | $17.65B | $16.07B | $16.35B | · | $17.95B | $17.29B | $18.26B | · | $18.06B | |
| Other Current Assets | $3.46B | $4.25B | $5.09B | $3.06B | $3.38B | $3.53B | $3.08B | $3.83B | $5.24B | $5.82B | · | $3.07B | $3.41B | $3.77B | · | $2.48B | |
| Current Assets | $75.35B | $74.82B | $74.71B | $77.11B | $75.65B | $73.19B | $68.64B | $67.34B | $69.95B | $67.47B | · | $70.14B | $67.76B | $68.71B | · | $68.34B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $13.02B | $13.00B | $12.87B | · | $12.63B | |
| Goodwill | $85.48B | $85.48B | $85.48B | $85.48B | $91.20B | $91.20B | $91.27B | $91.27B | $91.27B | $91.27B | $91.27B | $91.26B | $91.26B | $84.06B | $78.15B | $78.09B | |
| Intangibles | $24.64B | $25.07B | $25.51B | $25.98B | $26.22B | $26.57B | $27.32B | $27.82B | $28.31B | $28.77B | · | $29.62B | $30.12B | $26.37B | · | $25.16B | |
| Other Non-current Assets | $7.43B | $7.42B | $5.12B | $5.16B | $5.21B | $5.23B | $4.79B | $4.76B | $4.80B | $4.80B | · | $4.83B | $4.85B | $4.82B | · | $4.85B | |
| Total Assets | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Accrued Liabilities | $22.48B | $22.26B | $22.39B | $23.41B | $23.10B | $22.37B | $20.81B | $20.17B | $21.16B | $22.35B | · | $22.57B | $22.83B | $21.52B | · | $19.42B | |
| Short-term Debt | · | · | $0 | $1.25B | $3.04B | $1.26B | $2.12B | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Current Liabilities | $87.04B | $86.41B | $88.69B | $92.69B | $94.16B | $88.96B | $84.61B | $84.63B | $81.39B | $83.32B | · | $81.55B | $79.21B | $75.05B | · | $72.41B | |
| Capital Leases | $12.98B | $13.33B | $13.64B | $14.01B | $14.33B | $14.59B | $14.90B | $15.26B | $15.54B | $15.74B | · | $16.44B | $16.61B | $16.57B | · | $17.17B | |
| Deferred Tax | $3.77B | $3.77B | $3.83B | $3.55B | $3.60B | $3.66B | $3.81B | $3.63B | $4.05B | $4.18B | · | $4.25B | $4.59B | $4.09B | · | $3.51B | |
| Other Non-current Liabilities | $6.11B | $6.71B | $4.78B | $4.76B | $4.78B | $5.42B | $5.43B | $5.48B | $5.53B | $6.21B | · | $6.24B | $6.32B | $6.67B | · | $6.77B | |
| Total Liabilities | $173.87B | $175.34B | $178.16B | $182.22B | $180.79B | $178.47B | $177.49B | $177.32B | $177.37B | $175.59B | · | $176.80B | $177.07B | $167.75B | · | $160.20B | |
| Total Debt | · | · | · | $1.25B | $3.04B | $1.26B | · | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Common Stock | · | · | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | $18M | $18M | |
| Retained Earnings | $65.40B | $63.28B | $61.20B | $59.11B | $63.94B | $63.77B | $62.84B | $62.04B | $62.80B | $61.87B | · | $60.34B | $58.87B | $57.75B | · | $54.57B | |
| Treasury Stock | $36.85B | $36.71B | $36.79B | $36.78B | $36.85B | $36.73B | $36.82B | $36.81B | $36.92B | $36.77B | · | $33.83B | $33.93B | $33.80B | · | $30.33B | |
| AOCI | $188M | $201M | $406M | $416M | $272M | $59M | $-120M | $209M | $-319M | $-341M | · | $-1.00B | $-858M | $-875M | · | $-1.61B | |
| Stockholders' Equity | $79.70B | $77.46B | $75.21B | $72.93B | $77.38B | $76.93B | $75.56B | $74.94B | $74.93B | $73.97B | · | $74.34B | $72.73B | $71.38B | · | $70.68B | |
| Liabilities + Equity | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Shares Outstanding | 1,278,000,000 | 1,273,000,000 | 1,271,000,000 | 1,270,000,000 | 1,267,000,000 | 1,262,000,000 | 1,260,000,000 | 1,258,000,000 | 1,256,000,000 | 1,252,000,000 | · | 1,287,000,000 | 1,282,000,000 | 1,279,000,000 | · | 1,315,000,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.13B | $1.11B | $1.15B | $1.13B | $1.17B | $1.15B | $1.15B | $1.16B | $1.15B | $1.14B | $1.13B | $1.13B | $1.10B | $1.00B | $1.04B | $1.04B | |
| Stock-based Comp | $176M | $266M | $135M | $138M | $136M | $126M | $137M | $133M | $133M | $137M | $127M | $154M | $204M | $103M | $106M | $105M | |
| Amort. of Intangibles | $431M | $442M | $507M | $500M | $494M | $499M | $478M | $507M | $507M | $508M | $504M | $509M | $485M | $402M | $420M | $458M | |
| Other Non-cash | · | $-75M | · | · | · | $1.50B | · | · | · | $2.52B | · | · | · | $4.20B | · | · | |
| Operating Cash Flow | $6.34B | $4.25B | $3.39B | $796M | $1.90B | $4.56B | $1.86B | $-745M | $3.09B | $4.90B | $-2.64B | $2.72B | $5.91B | $7.44B | $-1.95B | $9.12B | |
| CapEx | $691M | $849M | $784M | $698M | $607M | $743M | $768M | $670M | $638M | $705M | $911M | $545M | $591M | $984M | $688M | $580M | |
| Investing Cash Flow | $-1.88B | $-874M | $-2.00B | $-2.09B | $-1.02B | $-762M | $-547M | $-3.35B | $-1.62B | $-2.09B | $-1.24B | $-771M | $-10.36B | $-8.51B | $-119M | $-805M | |
| Debt Issued | · | · | $0 | $3.97B | · | · | $2.95B | $0 | $4.96B | $0 | $0 | $0 | $4.95B | $5.95B | $0 | $0 | |
| Net Debt Issued | · | $-1.52B | · | · | · | $-743M | · | · | · | $-18M | · | · | · | $5.59B | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $0 | $0 | $0 | $-1M | $-3M | $3.03B | $-1M | $-3M | $-2M | $2.02B | $1.50B | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $-3.03B | · | · | · | $-2.02B | · | · | |
| Dividends Paid | $878M | $847M | $845M | $846M | $866M | $840M | $838M | $837M | $858M | $840M | $779M | $779M | $795M | $779M | $719M | $726M | |
| Financing Cash Flow | $-2.69B | $-2.32B | $-2.03B | $-1.38B | $806M | $-2.33B | $431M | $-1.59B | $1.25B | $-1.23B | $-972M | $-2.70B | $3.63B | $2.73B | $-2.19B | $-3.22B | |
| Net Change in Cash | $1.77B | $1.06B | $-640M | $-2.67B | $1.68B | $1.46B | $1.74B | $-5.68B | $2.71B | $1.58B | $-4.85B | $-752M | $-828M | $1.65B | $-4.26B | $5.10B | |
| Taxes Paid | $374M | $-337M | $998M | $305M | $725M | $138M | $274M | $700M | $666M | $63M | $908M | $837M | $1.70B | $75M | $1.05B | $1.18B | |
| Free Cash Flow | · | $3.40B | · | · | · | $3.81B | · | · | · | $4.20B | · | · | · | $6.45B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $3.69B | · | · | · | $6.02B | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.4% | 4.7% | · | -3.1% | 2.4% | 3.6% | · | 0.87% | 3.3% | 2.6% | · | 4.1% | 3.6% | 4.0% | · | -4.8% | |
| Net Margin | 2.8% | 2.9% | · | -3.9% | 1.0% | 1.9% | · | 0.09% | 1.9% | 1.3% | · | 2.5% | 2.1% | 2.5% | · | -4.2% | |
| Pretax Margin | 3.8% | 3.9% | · | -3.4% | 1.7% | 2.8% | · | 0.11% | 2.6% | 1.8% | · | 3.4% | 2.9% | 3.4% | · | -5.5% | |
| EBITDA Margin | 5.5% | 5.8% | · | -2.0% | 3.6% | 4.8% | · | 0.87% | 3.3% | 3.9% | · | 4.1% | 3.6% | 5.2% | · | -4.8% | |
| ROA | 1.2% | 1.2% | · | -1.6% | 0.40% | 0.70% | · | 0.03% | 0.70% | 0.46% | · | 0.94% | 0.79% | 0.90% | · | -1.5% | |
| ROE | 3.8% | 3.8% | · | -5.4% | 1.3% | 2.4% | · | 0.12% | 2.4% | 1.5% | · | 3.1% | 2.6% | 2.9% | · | -4.7% | |
| ROIC | 4.4% | 4.5% | · | -5.0% | 1.8% | 2.9% | · | 0.74% | 3.1% | 2.1% | · | 3.7% | 3.3% | 3.6% | · | -4.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | 0.0 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | 5.3 | 4.7 | 5.9 | · | -6.9 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | |
| Inventory Turnover | 3.4 | 3.2 | · | 3.1 | 3.2 | 3.0 | · | 3.0 | 3.0 | 2.8 | · | 3.0 | 3.1 | 2.8 | · | 2.8 | |
| Receivables Turnover | 2.6 | 2.5 | · | 2.6 | 2.7 | 2.6 | · | 2.8 | 2.9 | 2.9 | · | 3.0 | 3.1 | 3.1 | · | 3.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $62.36 | $60.85 | · | $57.42 | $61.07 | $60.96 | · | $59.57 | $59.66 | $59.08 | · | $57.76 | $56.73 | $55.81 | · | $53.75 | |
| Revenue / Share | $82.44 | $78.52 | · | $81.06 | $77.89 | $74.83 | · | $75.80 | $72.47 | $69.80 | · | $69.58 | $69.09 | $66.06 | · | $61.72 | |
| Cash Flow / Share | · | $3.32 | · | · | · | $3.60 | · | · | · | $3.87 | · | · | · | $5.76 | · | · | |
| Cash / Share | $8.86 | $7.50 | · | $7.16 | $9.30 | $7.98 | · | $5.46 | $9.96 | $7.83 | · | $10.13 | $10.77 | $11.43 | · | $13.08 | |
| Dividend / Share | $0.67 | $0.67 | $0.67 | $0.67 | $0.67 | $0.67 | $0.67 | $0.67 | $0.67 | $0.67 | $0.60 | $0.60 | $0.60 | $0.60 | $0.55 | $0.55 | |
| EPS (TTM) | $3.79 | $2.28 | · | $0.38 | $3.58 | $4.19 | · | $3.95 | $5.63 | $5.70 | · | $6.67 | $2.33 | $3.14 | · | $2.51 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $415.09B | $407.90B | · | $394.08B | $386.64B | $378.96B | · | $368.91B | $363.25B | $360.94B | · | $347.81B | $339.20B | $330.92B | · | $315.23B | |
| Net Income TTM | $4.89B | $2.93B | · | $469M | $4.53B | $5.28B | · | $5.02B | $7.19B | $7.32B | · | $8.63B | $2.96B | $4.09B | · | $3.37B | |
| Market Cap | $132.21B | $91.43B | · | $95.75B | $87.40B | $85.50B | · | $79.10B | $74.18B | $99.86B | · | $89.86B | $88.62B | $95.04B | · | $125.41B | |
| Enterprise Value | · | · | · | $85.76B | $76.26B | $74.11B | · | $70.22B | $57.92B | $89.49B | · | · | $72.74B | · | · | · | |
| P/E | 27.3 | 31.5 | · | 198.4 | 19.3 | 16.2 | · | 15.9 | 10.5 | 14.0 | · | 10.5 | 29.7 | 23.7 | · | 38.0 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| P/B | 1.7 | 1.2 | · | 1.3 | 1.1 | 1.1 | · | 1.1 | 1.0 | 1.4 | · | 1.2 | 1.2 | 1.3 | · | 1.8 | |
| P / Cash Flow | · | 21.5 | · | · | · | 18.8 | · | · | · | 20.4 | · | · | · | 12.8 | · | · | |
| EV / Revenue | · | · | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | · | 0.2 | · | · | · | |
| Dividend Yield | 2.6% | 3.7% | · | 3.5% | 3.9% | 4.0% | · | 4.2% | 4.4% | 3.2% | · | 3.4% | 3.4% | 3.1% | · | 2.3% | |
| Earnings Yield | 3.7% | 3.2% | · | 0.50% | 5.2% | 6.2% | · | 6.3% | 9.5% | 7.1% | · | 9.6% | 3.4% | 4.2% | · | 2.6% | |
| Payout Ratio | · | 28.8% | · | · | · | 47.2% | · | · | · | 75.5% | · | · | · | 36.5% | · | · | |
| Annual Payout | $3.42B | $3.40B | · | $3.39B | $3.38B | $3.37B | · | $3.31B | $3.26B | $3.19B | · | $3.07B | $3.02B | $2.96B | · | $2.85B |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B |
| Betriebsgewinnmarge % | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% |
| Nettoergebnis | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B |
| Verwässerte EPS | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.0 | 0.0 | 0.0 | · | · |
| Liquiditätsgrad | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 |
| Quick Ratio | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B |
Institutionelle Eigentümer (13F) 2.275 Einreicher · $125.7B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
2.275
Gehaltener Wert
$125.7B
Neue Positionen
314
Geschlossene Positionen
93
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 314 (+117 vs. Vorquartal) | 93 (-96 vs. Vorquartal) | 799 (+75 vs. Vorquartal) | 755 (-20 vs. Vorquartal) | +50.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $12.747.461.705 | 123.223.409 | 10,14% | Aktien |
| VANGUARD GROUP INC | $9.579.508.282 | 120.709.530 | 7,62% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.618.974.924 | 83.315.369 | 6,86% | Aktien |
| Capital World Investors | $7.753.834.783 | 74.951.955 | 6,17% | Aktien |
| STATE STREET CORP | $6.236.318.558 | 60.283.408 | 4,96% | Aktien |
| Dodge & Cox | $5.173.820.539 | 50.012.765 | 4,12% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $3.496.725.140 | 33.801.113 | 2,78% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $3.079.404.427 | 29.899.653 | 2,45% | Aktien |
| FMR LLC | $2.991.837.927 | 28.920.617 | 2,38% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.755.624.444 | 26.637.259 | 2,19% | Aktien |
| Capital Research Global Investors | $2.516.851.376 | 24.329.151 | 2,00% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.398.868.007 | 23.188.670 | 1,91% | Aktien |
| JPMORGAN CHASE & CO | $2.290.461.677 | 22.112.970 | 1,82% | Aktien |
| Invesco Ltd. | $2.130.597.379 | 20.595.431 | 1,70% | Aktien |
| MORGAN STANLEY | $1.924.793.937 | 18.606.028 | 1,53% | Aktien |
| NORGES BANK | $1.866.126.481 | 18.038.922 | 1,49% | Aktien |
| Capital International Investors | $1.591.868.430 | 15.387.600 | 1,27% | Aktien |
| GOLDMAN SACHS GROUP INC | $1.387.451.459 | 13.411.807 | 1,10% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.371.677.011 | 13.259.314 | 1,09% | Aktien |
| Davis Selected Advisers | $1.227.594.458 | 11.865.916 | 0,98% | Aktien |
| PZENA INVESTMENT MANAGEMENT LLC | $1.217.558.500 | 11.769.536 | 0,97% | Aktien |
| NORTHERN TRUST CORP | $1.186.760.815 | 11.471.830 | 0,94% | Aktien |
| FRANKLIN RESOURCES INC | $1.032.982.350 | 9.985.330 | 0,82% | Aktien |
| Legal & General Group Plc | $948.946.746 | 9.172.999 | 0,76% | Aktien |
| Bank of New York Mellon Corp | $932.453.862 | 9.013.571 | 0,74% | Aktien |
| Clearbridge Investments, LLC | $883.116.767 | 8.536.952 | 0,70% | Aktien |
| ROYAL BANK OF CANADA | $880.475.000 | 8.511.113 | 0,70% | Aktien |
| GQG Partners LLC | $822.989.370 | 7.955.411 | 0,65% | Aktien |
| AMERIPRISE FINANCIAL INC | $821.911.618 | 7.943.034 | 0,65% | Aktien |
| Amundi | $778.468.900 | 7.525.080 | 0,62% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $763.688.490 | 7.381.983 | 0,61% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $741.242.940 | 7.165.229 | 0,59% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $595.969.397 | 8.298.098 | 0,47% | Aktien |
| Nuveen, LLC | $544.750.652 | 5.265.836 | 0,43% | Aktien |
| UBS Group AG | $544.267.107 | 5.261.161 | 0,43% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $524.415.257 | 5.069.263 | 0,42% | Aktien |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $511.339.969 | 4.942.871 | 0,41% | Aktien |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $499.125.457 | 4.824.799 | 0,40% | Aktien |
| CITADEL ADVISORS LLC | $497.856.229 | 4.812.530 | 0,40% | Aktien |
| DEUTSCHE BANK AG\ | $466.633.571 | 4.510.716 | 0,37% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $449.870.951 | 4.348.680 | 0,36% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $409.796.485 | 3.961.300 | 0,33% | Kaufoption |
| Allianz Asset Management GmbH | $391.245.314 | 3.781.975 | 0,31% | Aktien |
| WELLS FARGO & COMPANY/MN | $380.921.357 | 3.682.178 | 0,30% | Aktien |
| VIKING GLOBAL INVESTORS LP | $378.974.695 | 3.663.361 | 0,30% | Aktien |
| Swiss National Bank | $371.195.152 | 3.588.160 | 0,30% | Aktien |
| National Pension Service | $352.166.145 | 3.404.216 | 0,28% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $322.653.390 | 3.118.927 | 0,26% | Aktien |
| Russell Investments Group, Ltd. | $312.682.898 | 3.022.292 | 0,25% | Aktien |
| Holocene Advisors, LP | $310.524.210 | 3.001.684 | 0,25% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| CVS Caremark Corporation | 7. Januar 2011 | · | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 86 Insider · 48 Führungskräfte · 41 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| David J. Joyner | President, CEO and Chair | 1. April 2026 F | 70.349 | 0 | 0 | $0 |
| Karen S Lynch | President and CEO | 1. April 2024 A | 74.687 | 0 | 0 | $0 |
| Brian Newman | EVP, Chief Financial Officer | 31. Mai 2026 F | 3.008 | 0 | 0 | $0 |
| Thomas F. Cowhey | EVP and CFO | 1. April 2025 A | 41.109 | 0 | 0 | $0 |
| Shawn M Guertin | EVP & Chief Financial Officer | 1. April 2023 A | 34.706 | 0 | 0 | $0 |
| Eva C Boratto | EVP & CFO | 4. Mai 2021 S | 115.331 | 0 | 0 | $0 |
| David M Denton | EVP and CFO | 29. November 2018 S | 403 | 0 | 0 | $0 |
| David B Rickard | Chief Financial Officer | 14. Dezember 2009 M | 207.179 | 0 | 0 | $0 |
| Howard A Mclure | President, Caremark Pharm Serv | 2. November 2009 M | 0 | 0 | 0 | $0 |
| Jonathan C Roberts | EVP & Chief Operating Officer | 1. April 2022 A | 426.025 | 0 | 0 | $0 |
| James David Clark | SVP, Cont & Chief Acct Officer | 26. Juni 2026 F | 27.606 | 0 | 0 | $0 |
| Amy Compton-Phillips | EVP, Chief Medical Officer | 31. Mai 2026 F | 9.557 | 0 | 0 | $0 |
| Tilak Mandadi | EVP, Chief Exp & Tech Officer | 8. Mai 2026 S | 10.133 | 0 | 1 | $-6.230.379 |
| Prem S Shah | EVP and Group President | 31. März 2026 A | 64.356 | 0 | 0 | $0 |
| Heidi B Capozzi | EVP and Chief People Officer | 31. März 2026 A | 13.023 | 3 | 0 | $4.588 |
| Samrat S. Khichi | EVP, CPO and General Counsel | 31. März 2026 A | 33.421 | 0 | 0 | $0 |
| Steven H Nelson | EVP and President, Aetna | 31. März 2026 A | 2.900 | 1 | 0 | $1.289 |
| Sreekanth K Chaguturu | EVP and Chief Medical Officer | 1. April 2024 A | 23.666 | 0 | 0 | $0 |
| Laurie P. Havanec | EVP and Chief People Officer | 1. April 2024 A | 9.426 | 0 | 0 | $0 |
| Brian A Kane | EVP/President, Aetna | 1. April 2024 A | 12.569 | 0 | 0 | $0 |
| Finke Daniel P | EVP/Pres, Health Care Benefits | 1. April 2023 A | 35.068 | 0 | 0 | $0 |
| Michelle A Peluso | EVP and Co-President of Retail | 1. April 2023 A | 124.383 | 0 | 0 | $0 |
| Thomas M Moriarty | EVP & General Counsel | 31. Dezember 2022 F | 315.273 | 0 | 0 | $0 |
| Alan Lotvin | EVP&President-PharmacyServices | 4. August 2022 M | 109.183 | 0 | 0 | $0 |
| Troyen A Brennan | EVP and Chief Medical Officer | 3. April 2022 F | 232.676 | 0 | 0 | $0 |
| Neela Montgomery | EVP and Pres., Pharmacy/Retail | 1. April 2021 A | 29.502 | 0 | 0 | $0 |
| Lisa Bisaccia | Former EVP & Chief HR Officer | 1. April 2021 F | 66.417 | 0 | 0 | $0 |
| Joshua Matthew Flum | EVP, ENT STRATEGY & DIGITAL | 28. Februar 2021 F | 25.657 | 0 | 0 | $0 |
| Jonathan E. Mayhew | EVP - Transformation | 2. Dezember 2020 F | 6.855 | 0 | 0 | $0 |
| Derica W Rice | EVP & President, CVS Caremark | 28. Februar 2020 F | 26.827 | 0 | 0 | $0 |
| Kevin Hourican | EVP & President, CVS Pharmacy | 1. April 2019 A | 15.237 | 0 | 0 | $0 |
| Helena Foulkes | EVP & President-CVS Pharmacy | 16. Februar 2018 M | 45.107 | 0 | 0 | $0 |
| Robert O. Kraft | EVP and President - Omnicare | 3. April 2017 A | 92.360 | 0 | 0 | $0 |
| Andrew Sussman | EVP, Clinical Services | 3. April 2017 A | 16.433 | 0 | 0 | $0 |
| Stephen J Gold | EVP & CIO | 3. April 2017 A | 46.818 | 0 | 0 | $0 |
| Per Gh Lofberg | EVP | 2. Januar 2015 M | 23.419 | 0 | 0 | $0 |
| Mark Cosby | EVP & President-CVS/pharmacy | 30. September 2013 M | 45.955 | 0 | 0 | $0 |
| Laird Daniels | SVP, Cont & Chief Acct Officer | 1. April 2013 A | 17.845 | 0 | 0 | $0 |
| Douglas A Sgarro | EVP and CLO | 11. Mai 2012 M | 214 | 0 | 0 | $0 |
| Stuart M Mcguigan | SVP and CIO | 16. März 2012 M | 10.967 | 0 | 0 | $0 |
| Thomas M Ryan | Non-Executive Chairman | 3. April 2011 F | 1.156.702 | 0 | 0 | $0 |
| Sara Finley | SVP, Gen Counsel | 18. Februar 2011 F | 29.053 | 0 | 0 | $0 |
| Michael V Ferdinandi | Senior Vice President | 19. August 2009 S | 16.021 | 0 | 0 | $0 |
| Paula A Price | Controller | 12. Februar 2008 A | 16.498 | 0 | 0 | $0 |
| Edwin M Crawford | Chairman | 29. Oktober 2007 A | 135.572 | 0 | 0 | $0 |
| William R Spalding | EVP Caremark Pharmacy Services | 18. Juni 2007 M | 182 | 0 | 0 | $0 |
| Gregory S Weishar | Vice President | 3. April 2006 A | 30.161 | 0 | 0 | $0 |
| Larry D Solberg | Senior Vice President | 16. Februar 2006 A | 5.978 | 0 | 0 | $0 |
| ROBBINS LARRY | Direktor | 21. Mai 2026 S | 4.824.799 | 0 | 8 | $-352.750.556 |
| Fernando Aguirre | Direktor | 21. Mai 2026 D | 10.513 | 0 | 0 | $0 |
| Jeffrey R. Balser | Direktor | 14. Mai 2026 A | 15.717 | 0 | 0 | $0 |
| Douglas H. Shulman | Direktor | 14. Mai 2026 A | 5.929 | 0 | 0 | $0 |
| Leslie V Norwalk | Direktor | 14. Mai 2026 A | 7.376 | 0 | 0 | $0 |
| Michael F Mahoney | Direktor | 14. Mai 2026 A | 6.345 | 0 | 0 | $0 |
| Anne A. Finucane | Direktor | 14. Mai 2026 A | 591 | 0 | 0 | $0 |
| John E Gallina | Direktor | 14. Mai 2026 A | 582 | 0 | 0 | $0 |
| Guy P Sansone | Direktor | 14. Mai 2026 A | 15.106 | 0 | 0 | $0 |
| Scott J Kirby | Direktor | 14. Mai 2026 A | 14.434 | 0 | 0 | $0 |
| DECOUDREAUX ALECIA A | Direktor | 14. Mai 2026 A | 2.970 | 0 | 0 | $0 |
| David C Brown II | Direktor | 14. Mai 2026 A | 129.316 | 0 | 0 | $0 |
| Roger N Farah | Direktor | 30. November 2025 F | 19.438 | 0 | 0 | $0 |
| Mary L Schapiro | Direktor | 21. November 2024 A | 7.585 | 0 | 0 | $0 |
| Jean Pierre Millon | Direktor | 21. November 2024 A | 4.514 | 0 | 0 | $0 |
| Nancy Ann Deparle | Direktor | 21. November 2024 A | 34.169 | 0 | 0 | $0 |
| Edward J Ludwig | Direktor | 2. Mai 2024 P | 21.630 | 0 | 0 | $0 |
| William C Weldon | Direktor | 17. November 2022 A | 1.591 | 0 | 0 | $0 |
| Tony L White | Direktor | 11. Mai 2022 A | 37.852 | 0 | 0 | $0 |
| David W Dorman | Direktor | 11. Mai 2022 A | 109.875 | 0 | 0 | $0 |
| Larry J Merlo | Direktor | 31. Mai 2021 F | 632.313 | 0 | 0 | $0 |
| Mark T Bertolini | Direktor | 20. November 2019 A | 13.773 | 0 | 0 | $0 |
| Richard M Bracken | Direktor | 20. November 2019 A | 15.348 | 0 | 0 | $0 |
| Richard J Swift | Direktor | 20. November 2019 A | 7.336 | 0 | 0 | $0 |
| Kristen Gibney Williams | Direktor | 9. Mai 2013 A | 1.695 | 0 | 0 | $0 |
| C A Piccolo | Direktor | 14. Dezember 2012 S | 181.461 | 0 | 0 | $0 |
| Marian L Heard | Direktor | 8. November 2012 A | 11.346 | 0 | 0 | $0 |
| Edwin M Banks | Direktor | 15. März 2012 M | 23.187 | 0 | 0 | $0 |
| Terrence Murray | Direktor | 2. November 2011 A | 84.140 | 0 | 0 | $0 |
| Sheli Z Rosenberg | Direktor | 4. November 2010 A | 125.112 | 0 | 0 | $0 |
| JOYCE WILLIAM H | Direktor | 4. November 2010 A | 18.390 | 0 | 0 | $0 |
| Roger L Headrick | Direktor | 23. Mai 2007 P | 2.200 | 0 | 0 | $0 |
| Alfred J Verrecchia | Direktor | 7. März 2007 A | 0 | 0 | 0 | $0 |
| Don W Cornwell | Direktor | 22. Dezember 2006 A | · | 0 | 0 | $0 |
| Thomas P Gerrity | Direktor | 9. November 2006 A | 68.460 | 0 | 0 | $0 |
| Stanley P Goldstein | Direktor | 11. Mai 2006 J | 590.967 | 0 | 0 | $0 |
| Terry R Lautenbach | Direktor | 21. Mai 2004 A | 27.915 | 0 | 0 | $0 |
| Chris W Bodine | · | 18. Februar 2009 A | 23.132 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 157 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHF · iShares Trust | 13,37% | 1.839.467 SH | 11. September 2026 | Täglich |
| DUSA · Davis Fundamental ETF Trust | 5,28% | 642.932 NS | 31. Juli 2026 | N-PORT |
| GEND · Spinnaker ETF Series | 4,47% | 2.080 NS | 31. Juli 2026 | N-PORT |
| IYK · iShares Trust | 4,25% | 617.818 SH | 11. September 2026 | Täglich |
| CVGD · Elevation Series Trust | 4,14% | 54.893 NS | 31. Juli 2026 | N-PORT |
| PEZ · Invesco Exchange-Traded Fund Trust | 3,42% | 8.582 SH | 1. Oktober 2026 | Täglich |
| FMTM · EA Series Trust | 3,17% | 76.503 NS | 31. Juli 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2,83% | 2.458 NS | 31. Juli 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 2,70% | 158.312 NS | 31. Juli 2026 | N-PORT |
| SPDV · ETF Series Solutions | 2,29% | 28.879 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1,94% | 3.824.297 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 1,92% | 605.189 NS | 31. Juli 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,92% | 2.169.744 SH | 1. Oktober 2026 | Täglich |
| RPV · Invesco Exchange-Traded Fund Trust | 1,77% | 339.241 SH | 1. Oktober 2026 | Täglich |
| REVS · Columbia ETF Trust I | 1,68% | 53.828 NS | 31. Juli 2026 | N-PORT |
| IXJ · iShares Trust | 1,54% | 670.400 SH | 11. September 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 1,53% | 25.107 NS | 31. Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,47% | 149.525 SH | 1. Oktober 2026 | Täglich |
| PWV · Invesco Exchange-Traded Fund Trust | 1,41% | 298.497 SH | 1. Oktober 2026 | Täglich |
| SPVM · Invesco Exchange-Traded Fund Trust | 1,39% | 21.140 SH | 1. Oktober 2026 | Täglich |
| DVY · iShares Trust | 1,37% | 3.384.928 SH | 11. September 2026 | Täglich |
| VLUE · iShares Trust | 1,35% | 1.359.538 SH | 11. September 2026 | Täglich |
| CVAR · ETF Opportunities Trust | 1,21% | 4.966 NS | 31. Juli 2026 | N-PORT |
| GURU · Global X Funds | 1,19% | 6.951 NS | 31. Juli 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 1,13% | 40.514.000 | 1. Oktober 2026 | Täglich |
| RECS · Columbia ETF Trust I | 1,09% | 610.992 NS | 31. Juli 2026 | N-PORT |
| VRP · Invesco Exchange-Traded Fund Trust … | 1,06% | 31.397.000 | 1. Oktober 2026 | Täglich |
| FEUS · FlexShares Trust | 0,97% | 10.395 NS | 31. Juli 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,95% | 77.895 SH | 19. August 2026 | Täglich |
| EQWL · Invesco Exchange-Traded Fund Trust | 0,92% | 295.291 SH | 1. Oktober 2026 | Täglich |
| FXG · First Trust Exchange-Traded AlphaDE… | 0,82% | 18.035 NS | 31. Juli 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,81% | 90.308 SH | 1. Oktober 2026 | Täglich |
| LSEQ · Harbor ETF Trust | 0,80% | 1.171 NS | 31. Juli 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0,80% | 190.028 NS | 31. Juli 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,75% | 50.750 SH | 19. August 2026 | Täglich |
| MTUM · iShares Trust | 0,75% | 1.909.551 SH | 11. September 2026 | Täglich |
| UPSD · ETF Series Solutions | 0,74% | 8.286 NS | 31. Juli 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0,72% | 12.142 NS | 31. Juli 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,71% | 6.228 NS | 31. Juli 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,70% | 20.507.000 | 1. Oktober 2026 | Täglich |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,67% | 31.259.000 | 1. Oktober 2026 | Täglich |
| CATH · Global X Funds | 0,63% | 78.905 NS | 31. Juli 2026 | N-PORT |
| GSY · Invesco Actively Managed Exchange-T… | 0,63% | 24.935.000 | 1. Oktober 2026 | Täglich |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0,62% | 1.682.074 SH | 1. Oktober 2026 | Täglich |
| MGV · VANGUARD WORLD FUND | 0,62% | 801.966 SH | 19. August 2026 | Täglich |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,58% | 36.106 NS | 31. Juli 2026 | N-PORT |
| FFLV · FIDELITY COVINGTON TRUST | 0,57% | 900 NS | 31. Juli 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,55% | 715.000 | 1. Oktober 2026 | Täglich |
| VYM · VANGUARD WHITEHALL FUNDS | 0,55% | 5.122.611 SH | 19. August 2026 | Täglich |
| PDP · Invesco Exchange-Traded Fund Trust | 0,51% | 86.857 SH | 1. Oktober 2026 | Täglich |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,50% | 40.184 NS | 31. Juli 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,49% | 12.134.319 SH | 19. August 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,48% | 710.848 NS | 31. Juli 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,47% | 302.533 NS | 31. Juli 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,46% | 529.245 SH | 1. Oktober 2026 | Täglich |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,46% | 13.367.000 | 30. September 2026 | Täglich |
| IWX · iShares Trust | 0,45% | 185.452 SH | 11. September 2026 | Täglich |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,45% | 293.814 SH | 19. August 2026 | Täglich |
| IVE · iShares Trust | 0,41% | 2.119.397 SH | 11. September 2026 | Täglich |
| DIVB · iShares Trust | 0,41% | 87.120 SH | 11. September 2026 | Täglich |
| CHRI · Global X Funds | 0,41% | 310 NS | 31. Juli 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,40% | 17.702 NS | 31. Juli 2026 | N-PORT |
| IUSV · iShares Trust | 0,39% | 1.116.077 SH | 11. September 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,37% | 774.792 SH | 19. August 2026 | Täglich |
| ESG · FlexShares Trust | 0,37% | 4.650 NS | 31. Juli 2026 | N-PORT |
| ILCV · iShares Trust | 0,35% | 49.213 SH | 11. September 2026 | Täglich |
| IWD · iShares Trust | 0,33% | 2.852.019 SH | 11. September 2026 | Täglich |
| GLBL · Pacer Funds Trust | 0,32% | 34 NS | 31. Juli 2026 | N-PORT |
| EGLE · Global X Funds | 0,31% | 65 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,30% | 57.429 SH | 19. August 2026 | Täglich |
| OEF · iShares Trust | 0,26% | 540.125 SH | 11. September 2026 | Täglich |
| INFO · Harbor ETF Trust | 0,25% | 20.350 NS | 31. Juli 2026 | N-PORT |
| MGC · VANGUARD WORLD FUND | 0,25% | 255.122 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,23% | 290.253 SH | 19. August 2026 | Täglich |
| TOPC · iShares Trust | 0,23% | 777 SH | 11. September 2026 | Täglich |
| IWL · iShares Trust | 0,22% | 49.933 SH | 11. September 2026 | Täglich |
| VV · VANGUARD INDEX FUNDS | 0,21% | 1.490.162 SH | 19. August 2026 | Täglich |
| XYLD · Global X Funds | 0,21% | 64.877 NS | 31. Juli 2026 | N-PORT |
| XTR · Global X Funds | 0,21% | 96 NS | 31. Juli 2026 | N-PORT |
| XVV · iShares Trust | 0,21% | 14.653 SH | 11. September 2026 | Täglich |
| EUSA · iShares, Inc. | 0,21% | 41.666 SH | 11. September 2026 | Täglich |
| XRMI · Global X Funds | 0,21% | 990 NS | 31. Juli 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,21% | 64.355 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,21% | 44.781 NS | 31. Juli 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 174.338 NS | 31. Juli 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,20% | 106.735 NS | 31. Juli 2026 | N-PORT |
| XYLG · Global X Funds | 0,20% | 1.250 NS | 31. Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,20% | 21.382 NS | 31. Juli 2026 | N-PORT |
| ADME · ETF Series Solutions | 0,20% | 5.697 NS | 31. Juli 2026 | N-PORT |
| XCLR · Global X Funds | 0,20% | 69 NS | 31. Juli 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,20% | 33.144.255 SH | 19. August 2026 | Täglich |
| TOV · EA Series Trust | 0,20% | 5.061 NS | 31. Juli 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0,20% | 44.949 NS | 31. Juli 2026 | N-PORT |
| LRGF · iShares Trust | 0,20% | 76.567 SH | 11. September 2026 | Täglich |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,20% | 37.793 SH | 1. Oktober 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,19% | 389.482 NS | 31. Juli 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,19% | 108 NS | 31. Juli 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,19% | 4.814 NS | 31. Juli 2026 | N-PORT |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,19% | 212.337 SH | 19. August 2026 | Täglich |
| QDPL · Pacer Funds Trust | 0,19% | 30.732 NS | 31. Juli 2026 | N-PORT |
| EVUS · iShares Trust | 0,19% | 7.499 SH | 11. September 2026 | Täglich |
| IVV · iShares Trust | 0,19% | 16.082.099 SH | 11. September 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,18% | 2.050.840 SH | 1. Oktober 2026 | Täglich |
| SIZE · iShares Trust | 0,18% | 8.166 SH | 11. September 2026 | Täglich |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,18% | 27.242 NS | 31. Juli 2026 | N-PORT |
| ILCB · iShares Trust | 0,18% | 24.548 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,18% | 40.509.855 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,18% | 108.067 SH | 19. August 2026 | Täglich |
| IWB · iShares Trust | 0,17% | 888.287 SH | 11. September 2026 | Täglich |
| IYY · iShares Trust | 0,17% | 54.746 SH | 11. September 2026 | Täglich |
| USCL · iShares Trust | 0,17% | 50.655 SH | 11. September 2026 | Täglich |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,17% | 22.631 NS | 31. Juli 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,17% | 7.610 SH | 1. Oktober 2026 | Täglich |
| IWV · iShares Trust | 0,17% | 354.060 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,17% | 34.918 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,17% | 53.112 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,17% | 197.043 NS | 31. Juli 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,17% | 220.176 SH | 1. Oktober 2026 | Täglich |
| ITOT · iShares Trust | 0,17% | 1.661.154 SH | 11. September 2026 | Täglich |
| HCMT · Direxion Shares ETF Trust | 0,16% | 8.880 NS | 31. Juli 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,16% | 15.076 SH | 1. Oktober 2026 | Täglich |
| ACVF · ETF Opportunities Trust | 0,16% | 2.271 NS | 31. Juli 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,16% | 675.214 SH | 11. September 2026 | Täglich |
| SPXL · Direxion Shares ETF Trust | 0,15% | 99.749 NS | 31. Juli 2026 | N-PORT |
| TOK · iShares Trust | 0,14% | 3.579 SH | 11. September 2026 | Täglich |
| PHDG · Invesco Actively Managed Exchange-T… | 0,14% | 1.007 SH | 1. Oktober 2026 | Täglich |
| URTH · iShares, Inc. | 0,13% | 114.536 SH | 11. September 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,13% | 70.355 SH | 1. Oktober 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,12% | 539.188 NS | 31. Juli 2026 | N-PORT |
| ACWI · iShares Trust | 0,12% | 406.018 SH | 11. September 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,11% | 1.069.623 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,10% | 5.157 NS | 31. Juli 2026 | N-PORT |
| QLC · FlexShares Trust | 0,09% | 8.960 NS | 31. Juli 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,08% | 1.368 NS | 31. Juli 2026 | N-PORT |
| CRBN · iShares Trust | 0,05% | 6.619 SH | 11. September 2026 | Täglich |
| FBCG · FIDELITY COVINGTON TRUST | 0,05% | 35.048 NS | 31. Juli 2026 | N-PORT |
| GLOF · iShares Trust | 0,02% | 478 SH | 11. September 2026 | Täglich |
| LGDX · Tidal Trust III | 0,02% | 251 NS | 31. Juli 2026 | N-PORT |
| GTOS · Invesco Actively Managed Exchange-T… | 0,02% | 21.000 | 1. Oktober 2026 | Täglich |
| GTO · Invesco Actively Managed Exchange-T… | 0,01% | 419.000 | 1. Oktober 2026 | Täglich |
| PEVC · Pacer Funds Trust | 0,01% | 3 NS | 31. Juli 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0,01% | 600.000 SH | 11. September 2026 | Täglich |
| DFVX · Dimensional ETF Trust | 0,01% | 517 NS | 31. Juli 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VGMS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| VCEB · VANGUARD WORLD FUND | · | · | 30. Juli 2026 | Täglich |
CVS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 33 Analysten
KAUF
Median-Ziel
$116.00
+34,2%
8 24,2%
Starker Kauf
20 60,6%
Kauf
5 15,2%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
25 Analysten · 2026-09-28Mittelwert-Ziel $116.28 +34,5%
← Unter allen Zielen
Aktueller Preis $86.46
Tief$103.00
Mittelwert$116.28
Hoch$148.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
As Americans go direct with GLP-1 prescriptions, Walmart, Costco, Amazon will be big weight-loss winners
CNBC · 2 Monate vor
What A Patient Holder Is Really Paying For CVS Health Stock
Yahoo Finance · 2 Monate, 2 Wochen vor
Markt-Update: CVS, ETN, KMB, KO, PSX
Yahoo Finance · 4 Monate, 2 Wochen vor
Jim Cramer zu CVS: „Ich würde argumentieren, dass es billiger ist“
Yahoo Finance · 4 Monate, 3 Wochen vor
Warum der CVS-Aktienkurs am Mittwoch explodierte
Nasdaq · 4 Monate, 3 Wochen vor
Jim Cramer macht eine bedeutende Aussage über CVS Corporation (CVS)
Yahoo Finance · 5 Monate vor
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 2,08
Einstieg
$93.31
R:R 2,08
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 1,71
Einstieg
$99.12
R:R 1,71
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026